For the Inventor, By the Inventor

Enter inventor name

Shanghai, China

Weidong Li

USPTO Granted Patents = 16 (Patent Applications = 1)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 7.6

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

Yangtze River Pharmaceutical Group Co., Ltd.

Shandong Danhong Pharmaceutical Co., Ltd.

Hubei Bio-pharmaceutical Industrial Technological Institute Inc.

Humanwell Healthcare (group) Co., Ltd.

6. 2 out of 118

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Luoxin Pharmaceutical (shanghai) Co., Ltd.

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.

Genfleet Therapeutics (shanghai) Inc.

10. 1 out of 65

Medshine Discovery Inc.

11. 1 out of 11

Qilu Pharmaceutical Co., Ltd.

12. 1 out of 19

Discovery Energy, LLC

where one patent can have more than one assignee

Years Active: 2019-2025

where 'Filed Patents' based on already Granted Patents

16 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. D1089322 - Engine (2025-08-19),

2. 11465995 - Crystal and salt forms of tricyclic compound and preparation process thereof (2022-10-11),

3. 11236112 - Crystal form and salt form of TGF-βRI inhibitor and preparation method therefor (2022-02-01),

4. 11180501 - Crystal form of β-lactamase inhibitor and preparation method therefor (2021-11-23),

5. 11059853 - Crystalline or amorphous form of steroid derivative FXR agonist, preparation method therefor and use thereof (2021-07-13),

6. 11034653 - Crystal form of estrogen receptor inhibitor and preparation method therefor (2021-06-15),

7. 10941150 - Salt type and crystal type of 4h-pyrazolo [1, 5-alpha] benzimidazole compound and preparation method and intermediate thereof (2021-03-09),

8. 10912775 - Crystal form of orexin receptor antagonist compound, and preparation method and application thereof (2021-02-09),

9. 10898486 - Crystal form of orexin receptor antagonist compound, and preparation method and application thereof (2021-01-26),

10. 10874674 - Crystal form of orexin receptor antagonist compound, and preparation method and application thereof (2020-12-29),

11. 10858322 - Process for preparing 1-isobutyryl-1'-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[D]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-one (2020-12-08),

12. 10668066 - Crystal form of orexin receptor antagonist compound, and preparation method and application thereof (2020-06-02),

13. 10633347 - Crystal form B of 1-isobutyryl-1'-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[d]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-one (2020-04-28),

14. 10626107 - Crystal form, salt type of substituted 2-hydro-pyrazole derivative and preparation method therefor (2020-04-21),

15. 10428073 - Salt type and crystal type of 4H-pyrazolo [1, 5-alpha] benzimidazole compound and preparation method and intermediate thereof (2019-10-01),

Title: Inventor Spotlight: Weidong Li – Leading the Way in Pharmaceutical Innovations

Introduction: Weidong Li, a brilliant inventor hailing from Shanghai, China, has made significant strides in the field of pharmaceutical research and development. With 15 patents to his name, his contributions to the industry are truly groundbreaking.

Latest Patents: Weidong Li's latest patents showcase his expertise in developing innovative pharmaceutical compounds. One notable patent is for the crystal and salt forms of a tricyclic compound, with applications in treating diseases related to the S1P1 receptor. Another patent focuses on a TGF-βR1 inhibitor, offering new possibilities for cancer treatment.

Career Highlights: Weidong Li has worked with esteemed companies such as Shanghai Haiyan Pharmaceutical Technology Co., Ltd. and Yangtze River Pharmaceutical Group Co., Ltd. His experience in these leading pharmaceutical firms has shaped his approach to innovation and fueled his passion for developing cutting-edge medicines.

Collaborations: Throughout his career, Weidong Li has collaborated with talented individuals in the field. Notable coworkers include Zheng Wang and Haiying He, whose expertise has complemented his own, leading to successful projects and advancements in pharmaceutical research.

Conclusion: In conclusion, Weidong Li's groundbreaking work in the pharmaceutical industry has not only led to the development of innovative compounds but has also set a standard for excellence in the field. His patents reflect his dedication to improving healthcare outcomes and his relentless pursuit of innovation. We look forward to seeing more revolutionary inventions from this visionary inventor.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…